Jinggou Biotechnology
精构生物
Jinggou Biotechnology (精构生物) is a Hangzhou-based synthetic biology startup focused on nutrition and health applications. In September 2025, the company closed a Series A round of tens of millions of yuan with Dalton Venture (道彤投资) as a participant, with proceeds earmarked for R&D and production capacity expansion to scale high-value nutritional supplements and feed additives . Dalton Venture highlighted the founding team's extensive industry experience and forward-looking product selection capabilities as key reasons for the investment .
AI-generated — may contain errors, please verify.
Coverage
A Decade of Dalton, Igniting a New Chapter of Intelligence | Dalton Venture's 2025 Annual Partners Meeting and 10th Anniversary Forum Concludes Successfully
Together, Toward the Brilliance and Distant Horizons of the Next Decade
Wanwu Capital's Bio-Manufacturing Industry Partners Conference Convenes in Shanghai! Shanghai's First Bio-Manufacturing Industry Fund Launches, Partners Discuss the Golden Decade
On the afternoon of October 23, 2025, the "Sheng Yan Wan Wu | Bio-Manufacturing Industry Value Partners Conference," co-hosted by Dalton Venture and OPM Biosciences [688293], was held in Shanghai. Centered on the theme "Sheng Yan Wan Wu" (Life Begets All Things), the conference brought together representatives from government agencies, scholars from research institutes, industry-leading entrepreneurs, fund investors, and ecosystem partners to explore cutting-edge trends in bio-manufacturing and pathways for industrial collaboration.
Jinggou Biotech Closes Tens of Millions of Yuan in Series A Funding, Dalton Venture Bets on Synthetic Biology for Nutrition and Health | Dalton News
Recently, emerging Chinese synthetic biology company **Hangzhou Jinggou Biotechnology Co., Ltd. (hereinafter referred to as "Jinggou Bio") announced the completion of a Series A financing round worth tens of millions of RMB, with Dalton Venture participating in the investment.** Proceeds from this round will be primarily directed toward R&D investment and production base capacity building, accelerating the scaled production of high-value-added nutritional health and feed additive products, and advancing the commercialization of green bio-manufacturing.
